Celgene and Novartis Pharma Sue Mylan Pharmaceuticals

  • April 12, 2011

Celgene and Novartis Pharma files suit against Mylan Pharmaceuticals over six patents related to extended release dexmethylphenidate hydrochloride capsules. 4/1, District of New Jersey, 2:2011cv01882.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×